Page last updated: 2024-10-21

tacrine and Chronic Disease

tacrine has been researched along with Chronic Disease in 5 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
" This article reviews basic approaches in pharmacoeconomics; current knowledge of costs related to dementia; assessment of quality of life in patients with cognitive impairment; models of relationships among degree of cognitive impairment, caregiver burden, and health care utilization; existing pharmacoeconomic guidelines for drug studies; pharmacoeconomic studies of tacrine, a drug used in Alzheimer disease; and further work needed to advance the critical area of pharmacoeconomic studies in dementia."3.69Pharmacoeconomics of dementia. ( Whitehouse, PJ, 1997)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, X1
Tian, J1
Sun, S1
Dong, Q1
Zhang, F1
Zhang, X1
Shu, XJ1
Liu, W1
Zhang, L1
Yang, R1
Yi, HL1
Li, CL1
Ye, YJ1
Ai, YX1
Zhao, Q1
Murakami, Y1
Tohda, M1
Obi, R1
Shimada, Y1
Matsumoto, K1
Hanus, H1
Tůtma, I1
Zapletálek, M1
Fusek, J1
Hrdina, V1
Whitehouse, PJ1

Other Studies

5 other studies available for tacrine and Chronic Disease

ArticleYear
(-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model.
    Scientific reports, 2016, 06-28, Volume: 6

    Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebrovascular Disorders; Chronic Di

2016
Effect of bis(7)-tacrine on cognition in rats with chronic cerebral ischemia.
    Neuroscience letters, 2012, Mar-23, Volume: 512, Issue:2

    Topics: Animals; Apoptosis; Brain Ischemia; Chronic Disease; Cognition; Hippocampus; Male; Maze Learning; Ne

2012
Chotosan, a kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition behaviors and central cholinergic systems in mice.
    Journal of pharmacological sciences, 2007, Volume: 103, Issue:4

    Topics: Acetylcholinesterase; Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Cere

2007
Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
    Homeostasis in health and disease : international journal devoted to integrative brain functions and homeostatic systems, 1991, Volume: 33, Issue:5-6

    Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Chronic Disease; Dyskinesia, Drug-Induced; Euph

1991
Pharmacoeconomics of dementia.
    Alzheimer disease and associated disorders, 1997, Volume: 11 Suppl 5

    Topics: Alzheimer Disease; Chronic Disease; Clinical Trials, Phase III as Topic; Cognition Disorders; Costs

1997